Cosmax Nbt, Inc.

₩4,015As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:222040Healthcare
Country South Korea
PE (Fwd) •••
TSR 10Y CAGR (18.80%)
Div yield —
ROE 37.84%
Pharmaceutical Preparations
Beta (5Y) 1.02
PE TTM 2.961
TSR TTM 31.64%
Mkt cap ₩82.53B
ROIC 10.34%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩3,919
(2.39%)
(86.29%)
Hold 10|6|5|10|7
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
56.82
61.42
66.56
68.79
11.70%
8.98%
13.73%
23.11%
Revenue₩B
5.122
5.281
5.524
5.759
2.02%
2.27%
3.04%
10.22%
Peers (US$60.85M)
Cap (US$)
PE
58.45M
7.521x
58.02M
13.45x
Capital
TTM
5Y
10Y
Leveragex
1.716
0.250
0.249
EBIT/Intx
0.136
0.032
0.035
Own earn%
(887.49)
82.09
72.62
Sh yield%
39.62
40.38
40.92
Owners
Insiders/Inst%
5.11
69.73
Short interest%
4.67
SBC / revenue%
3.84
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
13
Op margin range%
5–10
$1 testx
—
Incr. ROIC%
3